Femtech World Blog Cover

Aspivix mentioned in Femtech World about Serie A

December 13, 2022

Share this story:

More from our blog

ASPIVIX Announces That Contraception, an International Reproductive Health Journal, Has Published First-In-Women Results Using Novel Cervical Stabilizer In IUD Procedures

Read More

Aspivix receives U.S. FDA 510(k) Clearance for Carevix™, Their Novel Cervical Stabilizer

Read More

Aspivix mentioned in Femtech World about Serie A

Read More

ASPIVIX – Manufacturer of non-traumatic medical devices for gynecology – closes $5M Series A+ Funding Round and receives a large EUREKA-EUROSTARS grant co-funded by Innosuisse, the Swiss Innovation Agency.

Read More

10 Simple Steps Gynecologists Can Take to Enhance Patient Experience

Read More

5 Common Myths About Contraceptives

Read More

A modern approach to women’s healthcare

Read More

Clinical data show significantly lower IUD procedural pain and bleeding rates with Aspivix’s novel suction-based cervical device

Read More

Aspivix mentioned in Swissquote article about FemTech

Read More

Reshaping gynecology with women’s experience in mind

Read More